David Goel’s Veracyte VCYT Stock Holding History

David Goel’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-2,977,027	Closed	-$160M	–	28
2021 Q1	$160M	Buy	+2,977,027	New	+$171M	1.85%	20

Other funds holding VCYT

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

David Goel's VCYT Position: Q2 2021 in Review

David Goel sold out of Veracyte (VCYT) in Q2 2021, closing a stake of 2,977,027 shares — an estimated $160M sold.

David Goel first reported a position in VCYT in Q1 2021 and held it in 1 quarter. The position peaked at $160M in Q1 2021. 214 funds tracked by Wall St. Rank hold VCYT as of Q2 2021.

David Goel reported no remaining Veracyte position as of Q2 2021 after selling out during the quarter.
David Goel sold 2,977,027 Veracyte shares in Q2 2021, an estimated $160M.
David Goel first reported a position in Veracyte in Q1 2021 and held it in 1 quarter.
David Goel's Veracyte position peaked at $160M in Q1 2021.
214 funds tracked by Wall St. Rank held Veracyte as of Q2 2021.

Based on Matrix Capital Management Company's 13F filing for Q2 2021, filed 16 Aug 2021.